PharmaShots Weekly Snapshot (August 12-16, 2019)
Published: Aug 16, 2019 | Tags: 510(k), Ablation, Clearance, Profound Medical, Prostate Tissue, Receives, TULSA-PRO, The US FDA
Published: Aug 16, 2019 | Tags: CONFIRM, Hepatorenal Syndrome Type 1, Mallinckrodt, P-III, Positive, Reports, Results, Terlipressin
Published: Aug 15, 2019 | Tags: Baxter, Calorimetry, Clinical Nutrition, Collaborates, Commercialize, Cosmed, Device, Globally, Indirect, Q-NRG+, Support
Published: Aug 15, 2019 | Tags: EMA, Filgotinib, Galapagos, Gilead, MAA, Reports, Treat, Validation
Published: Aug 16, 2019 | Tags: Agreement, Angelman Syndrome, Develop, GeneTx, GTX-102, Signs, Ultragenyx
Published: Aug 16, 2019 | Tags: Approval, Entrectinib, FDA, Genentech, Metastatic Non-Small Cell Lung Cancer, NTRK, Gene, Fusion-Positive, Solid, Tumors, Receives, ROS1-Positive, Rozlytrek US
Published: Aug 14, 2019 | Tags: Evinacumab, Homozygous Familial Hypercholesterolemia, P-III, Positive, Regeneron, Reports, Results, Study
8. Regenerons Eylea (aflibercept) Receives the US FDAs Approval as a Prefilled Syringe
Published: Aug 14, 2019 | Tags: Aflibercept, Approval, EYLEA, FDA, Prefilled, Receives, Regeneron, Syringe, the US
Published: Aug 14, 2019 | Tags: 1L, Advanced, AstraZeneca, Lynparza, Maintenance Therapy, MSD, Ovarian Cancer, P-III, PAOLA-1, Report, Results, Study
Published: Aug 13, 2019 | Tags: Agreement, Bausch Health, Brodalumab, Commercialize, Develop, Enters, Europe, Leo Pharma, Moderate, Outside, Psoriasis, Severe, Sub-Licensing
Published: Aug 13, 2019 | Tags: Acalabrutinib, AstraZeneca, Breakthrough Therapy Designation, Calquence, Chronic Lymphocytic Leukemia, FDA, Receives, US
Published: Aug 13, 2019 | Tags: Adults, Approval, Chronic, European Commission, Ibrutinib, Imbruvica, Janssen, Lymphocytic Leukaemia, Receives, Waldenstrom's Macroglobulinemia
Published: Aug 13, 2019 | Tags: 1L, Adults, Approval, atezolizumab, ES-SCLC, Extensive-Stage, Small Cell Lung Cancer, Health Canada, Receives, Roche, Tecentriq
Published: Aug 13, 2019 | Tags: Eli Lilly, ixekizumab, IXORA-R Study, Moderate-to-Severe, P-IV, Patients, Plaque Psoriasis, Report, Results, Superiority, Taltz
15. Jazz Pharmaceutical to Acquire Cavion for the Expansion of its Sleep and Neurology Portfolio
Published: Aug 13, 2019 | Tags: Acquire, Cavion, Expansion, Jazz Pharmaceutical, Neurology, Portfolio, Sleep
Published: Aug 13, 2019 | Tags: Activated Phosphoinositide 3-kinase Delta Syndrome, Agreement, CDZ173, Commercialization, Development, Exclusive, Novartis, Pharming, Signs, Treat
Published: Aug 12, 2019 | Tags: Approval, Baxter, Health Canada, Maximizing, PrisMax System, Receives, Treatment
Published: Aug 12, 2019 | Tags: Advancement, Agreement, Boehringer Ingelheim, Cancer, Multi-Year, Signs, Therapies, University of Texas
Published: Aug 12, 2019 | Tags: Innovative, Medical Device Designation, NMPA, Novocure, Optune, Receive, Treating, Field, Delivery System, Tumor, Zai Lab
Published: Aug 12, 2019 | Tags: Advanced, Bavituximab, Cancer, Collaborate, Evaluate, Gastric Gastroesophageal, Keytruda, Merck, Oncologie, Treatment
21. Atricure to Acquire SentreHEART for Expansion of Therapie s to Treat Atrial Fibrillation
Published: Aug 12, 2019 | Tags: Acquire, Atricure, Expansion, SentreHEART ,Therapies, Treat
22. SMS-Oncology Signs a Clinical Trial Collaboration with Cytovation to Treat Solid Tumors
Published: Aug 12, 2019 | Tags: Clinical, Collaboration, Cytovation, Signs, SMS- Oncology, Solid, Treat, Trial, Tumors
Published: Aug 09, 2019 | Tags: Approval, , Biktarvy, CHMP, Emtricitabine, Gilead, Receives, Tenofovir Alafenamide, Treatment
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com